Skip to content
PeptideRank
Pallas Health logo

Provider review

Pallas Health cost: $325/mo tirzepatide

Its privacy policy details what goes to two AI vendors, and omits the ad pixel.

A Meta pixel fires on all 130 of its pages including the health intake and the patient portal, while the policy's visible text names Anthropic and OpenAI field by field and contains not one occurrence of Meta, Google, pixel, advertising or cookie.

Verified August 2026

Reviewed by Marcus Webb

Transparency scorecard

2 of 4 disclosed openly

What Pallas Health discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Not disclosed

Does not name a pharmacy or state a regulatory category anywhere on its own site.

State coverage published

Disclosed

Publishes which states it actually serves.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Not disclosed

The advertised price requires a prepay, auto-refill, or other commitment we found and named.

This review's stake, stated plainlysome of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

At a glance

Visit Pallas Health

Pharmacy

Not categorized

Labs

Unaddressed

States

Published state list

On this page

What it actually costs

What this price covers

Medication

Included

Provider visits

Not confirmed

Shipping

Not confirmed

Lab work

Not confirmed

Coaching

Not confirmed

The catch — Its per-month averages divide the 12-week charge by three, but twelve weeks is 84 days and a year holds 4.35 of them, not four. So $597 every 12 weeks is $2,596 a year rather than the $2,388 that "$199/mo" implies, and $897 is $3,900 rather than $3,588 — about $208 and $312 a year more than the advertised averages. Pallas does disclose the mechanism in fine print: "'Per-month average' prices reflect a 12-week renewal price spread across three months."

See plans at Pallas Health

Prices read from Pallas Health's own site · August 2026

What they advertise

"Compounded semaglutide injection is $139 for your first month, then $597 every 12 weeks ($199/mo average); compounded tirzepatide injection is $179 for your first month, then $897 every 12 weeks ($299/mo average)." NAD+ nasal $79 then $567 every 12 weeks; NAD+ injection $89 then $597. Brand-name cash prices: Zepbound $1,069, Ozempic $1,299, Wegovy $1,349, Mounjaro $1,349.

What you actually pay

$216.32/mo compounded semaglutide and $325.02/mo compounded tirzepatide. Those are its own 12-week charges converted to real calendar months — $2,596 and $3,900 a year respectively.

Money you will meet later

  • A $60 visit deposit applies in the states requiring a video visit, and its Terms allow it to be retained if you abandon the intake.
  • A voluntary refund loses the payment processor's costs plus $5 per refunded payment, and shipped medication is all-sales-final.
  • No milligram quantity is published at any price, on any product.

The bottom line

Pallas Health (Brentmoor, Inc.) sells compounded semaglutide and tirzepatide plus NAD+, alongside brand-name GLP-1s at cash prices, and its disclosure is genuinely strong in places: six pharmacies named with phone numbers, a named prescriber group, all 50 states with the seven that need a video visit called out, a LegitScript seal that resolves, and no savings claim anywhere for arithmetic to contradict. It also bills every 12 weeks rather than monthly, which it discloses in fine print — but the "$199/mo" and "$299/mo" averages it leads with divide by three, and twelve weeks is not three months. The real cost is $216 and $325 a month. The larger problem is a privacy policy that describes exactly which fields reach Anthropic and OpenAI while never mentioning the advertising pixel running on its intake funnel.

Pallas Health appears on our tirzepatide provider ranking, our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You want the pharmacy named — it names six, with phone numbers, and names the prescriber group too.
  • You want no savings games: it publishes no "Save $X" label anywhere, and it does disclose in fine print that its per-month figure is a 12-week price spread across three months.
  • You want to know before you start whether your state needs a video visit — it names all seven, plus DC.

Look elsewhere if

  • You care where your health data goes: an advertising pixel runs on its intake funnel and its privacy policy never mentions one.
  • You budget monthly — there is no monthly plan after the first month, only $597 or $897 charged every 12 weeks.
  • You want to know how much drug you are buying: no milligram quantity is published at any price.

What Pallas Health offers

Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.

Who fills your prescription

No category stated

Pallas Health does not name the pharmacy that fills your prescription.

What its own site says

Named, six of them. Its clinical disclosures page names Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills, each with a phone number — fuller disclosure than most providers here give. It explains the 503A and 503B categories generically but ties no pharmacy to one, and gates the actual license numbers behind an email request. One of the six, Belmar Pharma Solutions, has a March 2023 FDA warning letter on its record over section 503A violations, which FDA closed out that October.

What's the difference between 503A and 503B?

A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.

Where you can get it

Published state list

All 50 states plus DC, with no exclusions, and seven states — Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota and West Virginia — plus DC requiring a video visit first. No contradictions across its 51 state pages.

The honest cons

The part they would rather you skipped

Pallas Health's privacy policy is unusually specific in one direction and silent in the other. Its visible text names Anthropic and OpenAI and describes, field by field, what reaches them — your chat messages, attached photos, and the meal, dose, symptom, weight and mood entries the assistant reads to answer you. That level of detail proves the company knows how to write this section. The same document contains zero occurrences of Meta, Facebook, pixel, Google, Analytics, advertising or cookie. Meanwhile a Meta advertising pixel fires on all 130 pages of the site, including the weight-loss intake funnel and the patient portal, alongside Google Analytics and an affiliate tracker — and the word "cookie" appears on none of those 130 pages, with no consent banner anywhere. Sending health-intake traffic to an advertising network without disclosing it is the same fact pattern regulators have already acted on twice in this industry. Around it: an "As seen in Forbes Health" badge appears only on the affiliate landing page and nowhere in the 130-page site, and its href points back to Pallas's own funnel rather than to Forbes; and a "200,000+ patients" and "4.8 from 2,400+ reviews" claim sits alongside its own clinical page describing a July 2026 launch with waitlist patients.

  • A Meta advertising pixel runs on all 130 pages including the health intake funnel and the patient portal, and the privacy policy never mentions it — see this review's knock.
  • The word "cookie" appears on none of its 130 pages and there is no consent banner, on a site running three trackers.
  • Its "$199/mo" and "$299/mo" averages divide a 12-week charge by three; the real cost is $216 and $325 a month.
  • There is no monthly plan after the first month — the charge is $597 or $897 every 12 weeks.
  • No milligram quantity is published at any price, for any product.
  • Its "As seen in Forbes Health" badge appears only on the affiliate lander, with an href pointing back to its own funnel.
  • It claims 200,000+ patients and 2,400+ reviews beside its own page describing a July 2026 launch with waitlist patients.
  • "Unlimited 24/7 support" sits against a published phone line of Monday to Friday, 9 to 5.
  • Laboratory testing and injection supplies are both omitted from its enumerated list of what the price includes.

None of this is unique to Pallas Health — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.

Ready to get started?

Prices and plans in this category change often — check Pallas Health's current pricing before you decide. Ours was read from their own site in August 2026.

See Pallas Health pricing

Facts on this page reflect Pallas Health's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Pallas Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.

Pallas Health

2 compounds from $216/mo

Visit Pallas Health